Thu.Oct 31, 2024

article thumbnail

STAT+: These 10 scientists are leading a new generation of gene editors developing CRISPR medicines

STAT

Barely 12 years after the publication of the first papers unveiling CRISPR-Cas9, a powerful enzyme for editing DNA, sickle cell patients are now receiving the first approved CRISPR-based medicine, Casgevy. Hundreds of patients with other inherited diseases, cancers, and chronic bacterial and viral infections are enrolled in clinical trials testing other CRISPR treatments.

351
351
article thumbnail

Big Pharma earnings hang hope on the next generation of blockbusters

PharmaVoice

Pfizer, J&J, Biogen and Novartis are banking on new products to make up for maturing blockbusters, but future growth is not guaranteed.

254
254
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Limiting sugar in infancy is tied to less diabetes and hypertension in adulthood

STAT

Britain’s hardships during World War II famously included weeks of bombing during the Blitz, the mass evacuation of children, and food rationing. That rationing, researchers report, holds cautionary lessons for today on the health impact of consuming sugar early in life.  Black-and-white wartime photos capture long queues in the shops when supplies of meat, dairy, sugar, and other food were limited.

Diabetes 354
article thumbnail

Community Pharmacies in Crisis: Navigating the Challenges and Closures

Pharmaceutical Commerce

With today's pharmacy landscape shaken by unprecedented and wider disruption to healthcare support and delivery, community and independent entities strive to remain an integral cog in the mix.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Teva fined $503 million for disparaging a rival and using patents to thwart competition

STAT

Teva Pharmaceutical, the world’s largest generic drugmaker, was fined $503 million by European antitrust regulators for delaying competition to a blockbuster multiple sclerosis medicine. The European Commission found the company had artificially extended the patent protection of Copaxone and systematically spread misleading information about a rival product.

article thumbnail

See how your pharmacy compares as July Pharmacy First data released

The Pharmacist

July 2024 saw the highest number of pharmacies meeting the Pharmacy First monthly threshold since it increased to 10 consultations in May, according to the latest Pharmacy First data. Nationally, clinical pathway consultations and urgent medicine supply referrals increased overall. But minor illness referrals decreased in July 2024. Scroll down for our interactive Pharmacy First […] The post See how your pharmacy compares as July Pharmacy First data released appeared first on The Pharmacis

120
120

More Trending

article thumbnail

Roche weighs whether speedy approval path is open for latest Alzheimer’s drug

BioPharma Dive

In an investor presentation, executives hinted at the possibility of seeking an accelerated approval of trontinemab if it can significantly lower levels of amyloid in a Phase 3 trial.

120
120
article thumbnail

STAT+: Small mid-stage trial suggests targeted magnetic pulses to brain could slow Alzheimer’s

STAT

After spending decades fixated on a single hypothesis, Alzheimer’s researchers are increasingly searching for new ways to combat the devastating neurologic disease. One such approach — precisely targeting the brain with magnetic pulses — got a boost when mid-stage trial data was presented Thursday. Scientists reported that patients with mild or moderate Alzheimer’s who received the therapy, known as transcranial magnetic stimulation (TMS), experienced a 44% slowing in

305
305
article thumbnail

Why language training is crucial for healthcare teams

pharmaphorum

Effective language training for healthcare teams within the NHS is crucial for providing quality care and communication with diverse patient populations. Learn why it is essential for healthcare professionals.

article thumbnail

STAT+: Two generic drugmakers pay $49 million to settle price-fixing charges

STAT

Two generic drugmakers, Apotex and Heritage Pharmaceuticals, have agreed to pay a combined $49 million to settle allegations they fixed prices on numerous medicines, the first such agreements since state attorneys general began probing price-fixing in the generics industry a decade ago. In 2016, a number of states filed what eventually became the first in a trio of lawsuits against many of the largest generic companies for allegedly coordinating efforts to fix and maintain prices for dozens of m

Diabetes 295
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Teva fined €462.6m for antitrust delay to MS drug rivals

pharmaphorum

The European Commission has delivered a hefty fine to Teva for abusing a dominant position in multiple sclerosis by artificially extending the patent protection for former blockbuster Copaxone.

110
110
article thumbnail

Should race be used in clinical algorithms? How one doctor’s research is helping shape policy

STAT

When the murder of George Floyd in 2020 ignited calls for racial equity across the U.S., the field of medicine confronted its own thorny questions about race. James Diao, then a medical student at Harvard Medical School, was among the many people who zeroed in on one particular issue: If race is a social construct, why was it a factor in clinical tools used to determine a patient’s risk of disease?

article thumbnail

Biocon Biologics’ Bengaluru unit gets VAI classification by US FDA

Express Pharma

Biocon Biologics announces that its drug substance facility located at Biocon Campus, (Site 1) Bengaluru, has been classified as voluntary action indicated by the US Food and Drug Administration. This relates to the cGMP inspection conducted by the agency between February 20-28, 2024 and pertains to the supply of rh-Insulin (rhI) drug substance to the United States.

article thumbnail

STAT+: Apple claims new AirPod hearing aid feature is ‘clinical grade.’ Is it?

STAT

Apple this week officially released a batch of new health features for AirPods Pro that allow users to test their hearing and use the popular wireless headphones as hearing aids for milder forms of hearing loss.  After they were announced in September, audiologists and other experts immediately praised Apple’s efforts. Many people with hearing impairment  never get tested or seek treatment, so the new tools from one of the world’s largest tech companies could help boost a

298
298
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Evommune raises $115M to accelerate immune drug tests

BioPharma Dive

The biotech expects three Phase 2 readouts in urticaria and eczema over the next two years, and will keep its “options open” regarding an IPO, its CEO said.

article thumbnail

STAT+: Capricor and the FDA: A daring, risky filing strategy

STAT

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. Daring, risky, and entirely justified. That’s how I’d describe Capricor Therapeutics’ plan to seek early approval from the Food and Drug Administration for a stem cell therapy designed to improve heart function in patients with Duchenne muscular dystrophy.

217
217
article thumbnail

Compass points to job cuts as it defers trial readouts

pharmaphorum

Compass Pathways will cut its headcount by 30% as it defers phase 3 readouts for its psychedelic therapy for treatment-resistant depression.

115
115
article thumbnail

Bird flu is now in a pig (not good)

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Happy Halloween! Tonight I am going to a wedding rehearsal dressed as Jo March from “Little Women.” The bride and groom are dressing up as Buttercup and Westley from “The Princess Bride,” which is maybe the most precious thing I have ever heard.

251
251
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

CPE 'ready to restart CPCF negotiations immediately'

The Pharmacist

Community Pharmacy England (CPE) stands ready to restart contract negotiations 'immediately', it has said following yesterday's Autumn Budget. Janet Morrison, CPE chief executive, said she told ministers on Wednesday that 'without funding relief' there will be more pharmacies closing, and more patients going without advice or medicines and therefore turning to other parts of the […] The post CPE 'ready to restart CPCF negotiations immediately' appeared first on The Pharmacist.

article thumbnail

STAT+: Pharmalittle: We’re reading about the FDA listing Novo drugs as ‘available,’ pharma layoffs, and more

STAT

Rise and shine, everyone, another busy day is on the way. We can tell by the sudden presence of little ghouls and goblins walking past. No doubt, they are in search of the great pumpkin. We wish them luck, because you never know what you may find on that elusive quest. Of course, this calls for a cup of stimulation, and we are opening a new package of pecan pie for the occasion.

article thumbnail

Data and digital is a force to reckon with when it comes to India

Express Pharma

In a recent interview, Suneela Thatte, VP and Head – Healthcare R&D for India, Merck KGaA Darmstadt discussed the evolution and strategic significance of the company’s Global Capability Center (GCC) in India, established in 2020. She highlighted that while the GCC was initially set up for cost savings in drug development, the focus has shifted to harnessing India’s vast talent pool, particularly in the scientific and medical fields, in an interview with Viveka Roychowdhury India

article thumbnail

Opinion: Medicare’s hidden information hurts people, policy

STAT

Open enrollment season for Medicare, which began Oct. 15 and ends Dec. 7, triggers a deluge of information about various options. Since I’m a health care consultant and researcher as well as a Medicare beneficiary, I’ve looked critically at what we’re told and what we’re not. Unfortunately, information crucial both for the individual and for the broader policy goal of moving toward a “value-based” care system is often difficult to find or not available a

238
238
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Alpha-9's $175m third-round heads latest biotech financings

pharmaphorum

Our latest round-up of financings in the biotech sector features Alpha-9 Oncology, Axonis, Kivu Bio, SynOx, Agomab, and Blue Earth Therapeutics.

110
110
article thumbnail

The semaglutide drought may be ending

STAT

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Happy Halloween, and also happy Diwali! Today, we talk lots about semaglutide, we see how TMS is promising in Alzheimer’s disease, and unveil who you should be watching in the ever-evolving field of CRISPR gene editing.

article thumbnail

How CDMOs are Transforming the Industry

Drug Patent Watch

The pharmaceutical industry has undergone significant transformations in recent years, driven by the COVID-19 pandemic and the subsequent need for rapid innovation and adaptation.

97
article thumbnail

D.C. Diagnosis: The ghost of elections past, chiropractors for RFK Jr., and three appeals in a pod

STAT

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Hello, and happy Thursday! I hope you can take a moment for some spooky fun today amid the pre-election madness. Now’s as good a time as ever to subscribe to STAT+ and get full access to our best stories and events for 40% off.

215
215
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

NICE recommends remote monitoring technology for heart failure patients

Pharma Times

Heart failure accounted for approximately 90,000 hospital admissions in England in 2019 to 2020

Hospitals 121
article thumbnail

Oracle reveals new AI-powered EHR, insights from telehealth earnings, and more

STAT

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Oracle reveals ‘AI’ electronic health record software Oracle Health  this week began previewing its “next-generation” electronic health record software “powered by AI” that it claims was “built from the ground up” a

235
235
article thumbnail

Competitors race to launch GLP-1 drugs amid soaring weight loss demand

Outsourcing Pharma

Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are the companies racing for approval of their own versions of these highly coveted drugs.

91
article thumbnail

UK dementia clinical trial participation set to boost by ‘tens of thousands’

Pharma Times

The new Dementia Trials Accelerator is set to receive £20m of government funding

126
126
article thumbnail

Axonis raises $115 million to overcome drug resistance in epilepsy

Outsourcing Pharma

The Boston-based startup Axonis Therapeutics has bagged $115 million in a Series A round to fuel its pipeline of treatments for pain, epilepsy and other conditions.

94